AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT04242680 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Brainstim PPC
Description: The active tRNS will be delivered to bilateral PPC for five consecutive days for two weeks for a total of ten days.~tRNS will be delivered by a battery driven, random-noise current stimulator through a pair of saline-soaked sponge electrodes kept firm by elastic bands.~The electrodes will be placed on the left and right PPC, P3 and P4 position according to the 10-20 international EEG system for electrode placement, while participants will receive a usual treatment (cognitive training).~Stimulation intensity will be set at 0.75mA (100-500 Hz), the duration of stimulation will be 20 min.
Study NCT04242680 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Brainstim Sham
Description: The same electrode placement will be used as in the stimulation conditions (Brainstim DLPFC or Brainstim PPC), but the current will be applied for 30 s and will be ramped down without the participants awareness, and will be held five consecutive days for two weeks for a total of ten days.
Study NCT04242680 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cognitive Training
Description: A cognitive training (Vektor; Nemmi et al., 2016) will be adiministered concomitantly to Brainstim DLPFC, Brainstim PPC, Brainstim Sham for 20 min.~The training consisted of math exercises (number line, calculations) and math-related exercises (visuo-spatial working memory, mental rotation).
Study NCT04242680 — intervention group
Intervention type: BEHAVIORAL
Group type: SHAM_COMPARATOR
Intervention: Cognitive Training
Description: A cognitive training (Vektor; Nemmi et al., 2016) will be adiministered concomitantly to Brainstim DLPFC, Brainstim PPC, Brainstim Sham for 20 min.~The training consisted of math exercises (number line, calculations) and math-related exercises (visuo-spatial working memory, mental rotation).
Study NCT04667689 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: CAMPFIRE Online Cognitive Assessment for Cancer Patients
Description: Subjects will complete PROMIS Cognitive Function/Anxiety/Depression survey assessments and a short neuropsychological battery (NIH Toolbox) on an iPad while in clinic prior to beginning chemotherapy, again before a clinic visit scheduled between 6 - 9 weeks and, lastly, before a post-chemotherapy follow-up clinic visit. Within two weeks of their post-chemotherapy assessment, subjects will be asked to complete a feedback survey. The physician providers and/or their clinical team (e.g., nurse practitioners, registered nurses) will be asked to review subjects' cognitive assessment results and discuss referrals and/or recommendations, if appropriate.
Study NCT04630483 — intervention group
Intervention type: OTHER
Intervention: INHA
Description: NLR and PLR ratio will be assessed at postoperative 6th and 24th hours compared to preoperative values
Study NCT04630483 — intervention group
Intervention type: OTHER
Intervention: TIVA
Description: NLR and PLR ratio will be assessed at postoperative 6th and 24th hours compared to preoperative values
Study NCT01255046 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Donepezil,
Description: 10mg/tab, 1 tab/day for 72 weeks
Study NCT01255046 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: STA-1
Description: 300mg/tab, 2 tab/tid for 72 weeks
Study NCT01255046 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Description: 2 tab/tid for 72 weeks
Study NCT02405234 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Carbon Modular Radial Head replacement
Description: 'Carbon Modular Radial Head replacement: The Ascension Radial Head is made of pyrocarbon, a material that testing has shown to be both wear resistant and biocompatible and has been used in surgical implants for years. The introduction of the pyrocarbon head should alleviate the problems associated with wear debris and fragmentation experienced with the silicone radial spacer.
Study NCT02405234 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Metal Radial Head replacement
Description: Metal Radial Head replacement:The Ascension® Modular Radial Head (MRH) is an anatomically designed, single-use, modular prosthesis designed for replacement of the proximal end of the radius. FDA cleared this device for commercial distribution under 510(k) K032686. It is made from medical grade cobalt chromium alloy meeting ASTM F1537. Head components are available in six sizes and stem components are available in four sizes are interchangeable and assembled with a taper connection.
Study NCT02477722 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: EFP-NF
Study NCT02477722 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Sham
Study NCT00731393 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Thiomersal free trivalent influenza split vaccine 2003/2004
Description: 2 doses, intramuscular injection
Study NCT04625075 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Cardiac CT
Description: Cardiac CT to assess coronaries
Study NCT04625075 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Electrocardiogram (ECG)
Description: ECG to assess rhythm
Study NCT04625075 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Blood samples
Description: renal function liver function full blood count, hematocrit glucose
Study NCT04013646 — intervention group
Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: Active rehabilitation
Description: Physical therapy and occupational therapy are performed daily.
Study NCT04013646 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Active rehabilitation
Description: Physical therapy and occupational therapy are performed daily.
Study NCT00731393 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: GlaxoSmithKline Biologicals' Influsplit SSW®/Fluarix™ 2003/2004
Description: 2 doses, intramuscular injection
Study NCT01692730 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Enhanced Web Assisted Tobacco Intervention
Description: Subjects at community college campuses will be directed to a cessation website with current Public Health Service Guideline information and effective smoking cessation strategies, and some combination of novel interactive and social network features, including a variety of better-practice features recommended recent literature, and technologically advanced proactive features (e-mails, SMS texting, and social networking).
Study NCT01692730 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Basic Web Assisted Tobacco Intervention
Description: Subjects at community college campuses will be directed to a cessation website with current Public Health Service Guideline information and effective smoking cessation strategies, and with minimal interactive web-based features.
Study NCT02298751 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cue Exposure Treatment
Study NCT01382030 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: EIA chemotherapy
Description: ifosfamide 1500 mg/m² iv days 1 - 4, etoposide 125 mg/m² iv days 1 and 4, and adriamycin 50 mg/m² iv day 1
Study NCT00003292 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ifosfamide
Study NCT03297372 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: IOL implantation
Description: Implantation of monofocal IOL Micropure 1.2.3
Study NCT00437190 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: ATLANTIS™ Cervical Plate System and allograft
Description: Control treatment is commercially available allograft (without bone matrix paste) used in conjunction with the Medtronic Safamor Danek ATLANTIS™ Cervical Plate System.
Study NCT00437190 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: BRYAN Cervical Disc Prosthesis
Description: The intent is to treat stable degenerative disc disease by implanting the BRYAN Cervical Disc Prosthesis to provide motion like the normal cervical functional spinal unit.
Study NCT00967603 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: sunitinib
Description: oral sunitinib 37.5 mg daily
Study NCT00410683 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: clinical observation
Study NCT00410683 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: clinical observation
Study NCT00410683 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: adjuvant therapy
Study NCT00410683 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: adjuvant therapy
Study NCT00410683 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: 3-dimensional conformal radiation therapy
Study NCT04218981 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Antipsychotic drugs
Description: Choose one of these antipsychotics (olanzapine, risperidone; amisulpride) for schizophrenia group
Study NCT04218981 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Mood stabilizer
Description: Choose lithium or valproate for bipolar disorder group
Study NCT04218981 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Paroxetine
Description: Patients with major depressive disorder are treated with paroxetine
Study NCT04394494 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Motor Imagery. Imaging doing Extension exercises without actually doing them.
Description: This study will compare imagining doing specific extension based exercises for LBP vs. actually performing the exercises. This intervention will be just imaging doing the exercises.
Study NCT04394494 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Control: Physically performing extension based exercises.
Description: This study will compare imagining doing specific extension based exercises for LBP vs. actually doing them. This intervention will be actually, physically performing the exercises.
Study NCT00078260 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: pemetrexed
Description: A: 500 mg/m2, IV, q 21 days until disease progression~B: 900 mg/m2, IV, q 21 days until disease progression
Study NCT02898688 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Control Site
Description: Control sites will continue with their standard practice regarding discussing vaccines with their patients.
Study NCT02898688 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Control Site
Description: Control sites will continue with their standard practice regarding discussing vaccines with their patients.
Study NCT02898688 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Intervention Site
Description: Intervention Sites will each assign a Vaccine Champion and will have Assessment, Feedback, Incentives, and eXchange (AFIX) visits. AFIX is a quality improvement program to raise immunization coverage levels, reduce missed opportunities to vaccinate, and improve standards of practices at the provider level. A Continuing Medical Education (CME) module will be given to all providers, covering the recommended maternal vaccinations and how to talk to patients about vaccines. Intervention sites will have access to written materials covering all recommended maternal and infant vaccinations, the diseases they prevent, potential adverse reactions and common patient questions with talking points and references for each topic.
Study NCT02898688 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Patient-level Control Group
Description: Participants randomized the control arm will complete a computer-based questionnaire, on an iPad with a preloaded app. The questionnaire asks about vaccine knowledge, attitudes, and beliefs and the participant's intent to receive vaccinations during pregnancy and to vaccinate their baby. The questionnaire includes questions requiring a yes or no response, degree of agreement with vaccine-related statements (ranging from strongly agree to strongly disagree), questions to capture the vaccines participants plan to get for themselves and their children, and open-ended questions.
Study NCT02898688 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Patient-level Control Group
Description: Participants randomized the control arm will complete a computer-based questionnaire, on an iPad with a preloaded app. The questionnaire asks about vaccine knowledge, attitudes, and beliefs and the participant's intent to receive vaccinations during pregnancy and to vaccinate their baby. The questionnaire includes questions requiring a yes or no response, degree of agreement with vaccine-related statements (ranging from strongly agree to strongly disagree), questions to capture the vaccines participants plan to get for themselves and their children, and open-ended questions.
Study NCT02898688 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Patient-level Intervention Group
Description: Participants randomized to the intervention arm will complete a computer-based questionnaire on an iPad with a preloaded app, prior to watching informational videos covering topics on maternal and childhood vaccines. The questionnaire asks about vaccine knowledge, attitudes, beliefs, and the participant's intent to receive vaccinations during pregnancy and to vaccinate their baby. The questions require yes or no responses, degree of agreement with vaccine-related statements (ranging from strongly agree to strongly disagree), and open-ended responses. After watching at least one informational video, the participant completes a questionnaire asking about the perceived usefulness of the app, degree of agreement with the vaccine information presented in the video, and ways to make the app more useful to participants.
Study NCT02399293 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: N-back
Description: The N-back task required patients to monitor a continuous sequence of stimuli (in this experiment audio and visual stimuli). Press a button if the current stimulus is the same as that shown N back in the sequence. N increases if performance is good and decreases if performance is poor.~Subjects train for 20 days, 12 blocks a day, 20+N trials per block. That is 240 blocks in total. A minimum of 10 blocks per day counts as a successfully trained day.
Study NCT02399293 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Visual Search
Description: The Visual Search task consists of a NxN array of shapes. Press the button if a certain target stimulus is present in this array. N increases if performance is good and decreases if performance is poor.~Subjects train for 20 days, 12 blocks a day, 20+N trials per block. That is 240 blocks in total. A minimum of 10 blocks per day counts as a successfully trained day.
Study NCT02746315 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HS-20004
Study NCT02378155 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: SenSmart Model X-100, Nonin Medical
Description: Device to measure cerebral tissue oxygen saturation
Study NCT03856099 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TTAC-0001
Description: * Investigational product (IP): TTAC-0001~* Treatment groups: 3 dose groups~  * Dose group A : TTAC-0001 16 mg/kg on D1 and D15~ * Dose group B : TTAC-0001 20 mg/kg on D1 and D15~ * Dose group C : TTAC-0001 24 mg/kg on D1 and D15~* Cycle: 4 weeks (28 days per cycle)
Study NCT02181660 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Gilteritinib
Description: oral
Study NCT00611897 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: N-acetylcysteine and ketamine
Description: Active drug (N-acetylcysteine)
Study NCT00611897 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: placebo and ketamine
Description: placebo N-acetylcysteine
Study NCT04310150 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Collastat
Description: hemostatic agent that combine porcine-derived collagen thrombin
Study NCT04310150 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Floseal
Description: hemostatic agent that combine bovine-derived gelatin
Study NCT02746315 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Study NCT02793960 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: topical BPM31510 3.0% Cream
Description: Application of drug to lesions of epidermolysis bullosa
Study NCT05136716 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Traditional Physical Therapy
Description: Stretching for tight muscles, strengthening for weak muscles, postural reactions training, proprioceptive training, and walking training were all part of the neurodevelopmental treatment plan.
Study NCT05136716 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Hyperbaric oxygen therapy
Description: HBO2 therapy at a pressure of 1.7 atm For 60 minutes, participants breathed 100% O2.
Study NCT01882816 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: IMRT
Description: Patients will receive intensity-modulated radiation therapy (IMRT) in once-daily fractions (Monday through Friday, excluding holidays). A total dose of 70Gy is planned. Patients will be seen weekly during radiation as per standard procedure at MSKCC
Study NCT01882816 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: DWI MRI
Description: The DW and multiparametric MRI will be recommended for 3 months, 6 months, and then every 6 months (all +/- 4 weeks) until 2 years post-RT unless contraindicated for main campus patients only. This schedule may be altered, as clinically indicated.
Study NCT01882816 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Doxorubicin
Description: Low dose radiosensitizing doxorubicin at 10 mg/m2 will be administered weekly.
Study NCT01882816 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Modified Barium Swallow Impairment Profile (MBSImP)
Description: The MBSImP is a standardized tool which assesses swallowing impairment as it relates to oral, pharyngeal, and esophageal impairments.
Study NCT02752542 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy
Description: CBT will be delivered in a one-to-one face-to-face format by trained Masters or PhD level CBT therapists who will follow a protocol adapted from existing manuals and piloted in the participating centres. Up to 20 sessions will be offered over 18 weeks, initially twice per week, then weekly and later spaced to every other week. The treatment will have core obligatory modules and flexible elements adaptable to participant's maintaining factors.
Study NCT02752542 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pharmacotherapy
Description: Pharmacotherapy will be prescribed and adjusted by psychiatrists in 20-30 minute pharmacotherapy sessions once every two weeks. The manual-guided best-evidence pharmacotherapy will follow current guidelines for first, second and third line treatment.41 The primary focus will be on serotonin-reuptake inhibiting antidepressant (escitalopram 5-20mg, sertraline 50-200 mg daily) monotherapy, which may remain the only treatment for the majority of participants. Augmentation (aripiprazole 2-10mg, bupropione 150-450mg) will be offered to participants with partial response. The manual, developed as part of Canadian Biomarker Integration Network in Depression (CAN-BIND).43, also specifies admissible supportive therapeutic elements and prohibits CBT-specific techniques.
Study NCT02903485 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: nurses perform presurgical assessement and surveillance during surgery
Study NCT02903485 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: the anesthetic team performs presurgical assessement and surveillance during surgery
Study NCT01680211 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Salacia bark extract
Study NCT01680211 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Salacia leaf extract
Study NCT01680211 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Sesame seed extract
Study NCT01680211 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: TLC
Description: Lifestyle changes include diet, exercise, weight loss, etc.
Study NCT01680211 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: TLC
Description: Lifestyle changes include diet, exercise, weight loss, etc.
Study NCT01680211 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Study NCT04519333 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: drug(intradermal injection)
Description: The mesotherapy was performed by an experienced and trained physician using a disposable 4 mm and 6 mm long, 30 Gauge needles. Initially, a pharmacological mixture of 1 cc (2 mg) thiocolchicoside, 1 cc (16.2 mg) lidocaine and 1 cc (5 mg) tenoxicam was prepared for each treatment session, and 0.1-0.2 cc of this mixture was applied to each injection point with a depth of 1-3 mm using point by point intradermal method without causing papules.~In the systemic therapy group, we applied a 50 mg dexketoprofen (Revafen, Haver Pharma Pharmaceutical Co., Turkey) in 100 cc isotonic solution intravenously for 5 minutes.
Study NCT02260037 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Epinastine nasal
Study NCT02260037 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Study NCT06188611 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Huazhi Rougan Granule Placebo granule
Description: Experimental: Huazhi Rougan granule Placebo Comparator: Placebo granule Placebo Comparator: Placebo granule
Study NCT06188611 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Huazhi Rougan Granule Placebo granule
Description: Experimental: Huazhi Rougan granule Placebo Comparator: Placebo granule Placebo Comparator: Placebo granule
Study NCT03146260 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Conventional TESE
Description: usual procedure for sperm extraction
Study NCT03146260 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Microdissection TESE
Description: Procedure of extraction is performed under the operating microscope